{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T03:19:58Z","timestamp":1793762398169,"version":"4.6.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003787","name":"Natural Science Foundation of Hebei Province","doi-asserted-by":"publisher","award":["(H2018201289)"],"award-info":[{"award-number":["(H2018201289)"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403762"],"award-info":[{"award-number":["82403762"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hebei provincial government funded the clinical medicine outstanding talent training projec"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Renal interstitial fibrosis (RIF) is a common pathological feature and final manifestation of chronic progressive kidney disease. Although exosome-mediated intercellular communication is known to play a crucial role in RIF, the mechanism by which injured tubular epithelial cells (TECs) contribute to fibrogenesis remains incompletely understood. In this study, we investigated the role of exosomal miR-122-5p derived from TECs in modulating fibroblast activation and renal fibrosis. Exosomes were isolated from kidneys of unilateral ureteral obstruction (UUO) mice and from TGF-\u03b21-stimulated HK-2 cells. These exosomes were either co-cultured with fibroblasts (NRK-49F cells) or injected into UUO mice via the tail vein. High-throughput miRNA profiling was used to identify differentially expressed miRNAs in exosomes derived from HK-2 cells, and miR-122-5p was selected for further investigation based on expression level and bioinformatic prediction. Functional analyses were performed using miRNA mimics, inhibitors, and target validation assays. The results showed that exosomal miR-122-5p was significantly downregulated in both fibrotic kidneys and TGF-\u03b21-induced HK-2 cells. In vivo and in vitro, restoration of miR-122-5p levels markedly attenuated renal fibrosis, as evidenced by the reduction of fibrotic markers including \u03b1-smooth muscle actin, fibronectin, and collagen I. Mechanistically, miR-122-5p was found to directly target hypoxia-inducible factor 1-alpha (HIF-1\u03b1), thereby inhibiting activation of the TGF-\u03b21\/Smad signaling pathway. These findings suggest that decreased expression of miR-122-5p in TEC-derived exosomes promotes renal fibrosis through the HIF-1\u03b1\/TGF-\u03b21\/Smad axis, while reintroduction of miR-122-5p can effectively reverse these effects. Taken together, our study provides new insights into the intercellular communication between TECs and fibroblasts via exosomal miRNAs, and identifies miR-122-5p as a potential therapeutic target for the treatment of renal interstitial fibrosis.<\/jats:p>","DOI":"10.1038\/s41420-025-02739-8","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:01:52Z","timestamp":1761051712000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Exosomal miR-122-5p from tubular cells ameliorates renal interstitial fibrosis by regulating fibroblasts via HIF-1\u03b1"],"prefix":"10.1038","volume":"11","author":[{"given":"Jifeng","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengxia","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linqian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaomu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0567-3673","authenticated-orcid":false,"given":"Haisong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"key":"2739_CR1","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41392-023-01379-7","volume":"8","author":"R Huang","year":"2023","unstructured":"Huang R, Fu P, Ma L. Kidney fibrosis: from mechanisms to therapeutic medicines. Signal Transduct Target Ther. 2023;8:129. https:\/\/doi.org\/10.1038\/s41392-023-01379-7.","journal-title":"Signal Transduct Target Ther"},{"key":"2739_CR2","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1001\/jama.2019.14745","volume":"322","author":"TK Chen","year":"2019","unstructured":"Chen TK, Knicely DH, Grams ME. Chronic kidney disease diagnosis and management: a review. Jama. 2019;322:1294\u2013304. https:\/\/doi.org\/10.1001\/jama.2019.14745.","journal-title":"Jama"},{"key":"2739_CR3","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nrneph.2016.163","volume":"13","author":"RJ Glassock","year":"2017","unstructured":"Glassock RJ, Warnock DG, Delanaye P. The global burden of chronic kidney disease: estimates, variability and pitfalls. Nat Rev Nephrol. 2017;13:104\u201314. https:\/\/doi.org\/10.1038\/nrneph.2016.163.","journal-title":"Nat Rev Nephrol"},{"key":"2739_CR4","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41581-019-0248-y","volume":"16","author":"M Ruiz-Ortega","year":"2020","unstructured":"Ruiz-Ortega M, Rayego-Mateos S, Lamas S, Ortiz A, Rodrigues-Diez RR. Targeting the progression of chronic kidney disease. Nat Rev Nephrol. 2020;16:269\u201388. https:\/\/doi.org\/10.1038\/s41581-019-0248-y.","journal-title":"Nat Rev Nephrol"},{"key":"2739_CR5","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/s41392-022-01036-5","volume":"7","author":"Q Yuan","year":"2022","unstructured":"Yuan Q, Tang B, Zhang C. Signaling pathways of chronic kidney diseases, implications for therapeutics. Signal Transduct Target Ther. 2022;7:182. https:\/\/doi.org\/10.1038\/s41392-022-01036-5.","journal-title":"Signal Transduct Target Ther"},{"key":"2739_CR6","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1056\/NEJMc1504848","volume":"373","author":"DC Rockey","year":"2015","unstructured":"Rockey DC, Bell PD, Hill JA. Fibrosis\u2014a common pathway to organ injury and failure. N Engl J Med. 2015;373:96. https:\/\/doi.org\/10.1056\/NEJMc1504848.","journal-title":"N Engl J Med"},{"key":"2739_CR7","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nrneph.2014.246","volume":"11","author":"LL Falke","year":"2015","unstructured":"Falke LL, Gholizadeh S, Goldschmeding R, Kok RJ, Nguyen TQ. Diverse origins of the myofibroblast\u2014implications for kidney fibrosis. Nat Rev Nephrol. 2015;11:233\u201344. https:\/\/doi.org\/10.1038\/nrneph.2014.246.","journal-title":"Nat Rev Nephrol"},{"key":"2739_CR8","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/ki.2012.20","volume":"82","author":"I Grgic","year":"2012","unstructured":"Grgic I, Campanholle G, Bijol V, Wang C, Sabbisetti VS, Ichimura T, et al. Targeted proximal tubule injury triggers interstitial fibrosis and glomerulosclerosis. Kidney Int. 2012;82:172\u201383. https:\/\/doi.org\/10.1038\/ki.2012.20.","journal-title":"Kidney Int"},{"key":"2739_CR9","doi-asserted-by":"publisher","first-page":"9226","DOI":"10.1073\/pnas.1100629108","volume":"108","author":"BD Humphreys","year":"2011","unstructured":"Humphreys BD, Czerniak S, DiRocco DP, Hasnain W, Cheema R, Bonventre JV. Repair of injured proximal tubule does not involve specialized progenitors. Proc Natl Acad Sci USA. 2011;108:9226\u201331. https:\/\/doi.org\/10.1073\/pnas.1100629108.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2739_CR10","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s41580-023-00576-0","volume":"24","author":"AC Dixson","year":"2023","unstructured":"Dixson AC, Dawson TR, Di Vizio D, Weaver AM. Context-specific regulation of extracellular vesicle biogenesis and cargo selection. Nat Rev Mol Cell Biol. 2023;24:454\u201376. https:\/\/doi.org\/10.1038\/s41580-023-00576-0.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2739_CR11","doi-asserted-by":"publisher","unstructured":"Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367. https:\/\/doi.org\/10.1126\/science.aau6977.","DOI":"10.1126\/science.aau6977"},{"key":"2739_CR12","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1038\/ki.2011.292","volume":"80","author":"BW van Balkom","year":"2011","unstructured":"van Balkom BW, Pisitkun T, Verhaar MC, Knepper MA. Exosomes and the kidney: prospects for diagnosis and therapy of renal diseases. Kidney Int. 2011;80:1138\u201345. https:\/\/doi.org\/10.1038\/ki.2011.292.","journal-title":"Kidney Int"},{"key":"2739_CR13","doi-asserted-by":"publisher","first-page":"237","DOI":"10.7150\/thno.21945","volume":"8","author":"C He","year":"2018","unstructured":"He C, Zheng S, Luo Y, Wang B. Exosome theranostics: biology and translational medicine. Theranostics. 2018;8:237\u201355. https:\/\/doi.org\/10.7150\/thno.21945.","journal-title":"Theranostics"},{"key":"2739_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12203","volume":"11","author":"S Chen","year":"2022","unstructured":"Chen S, Zhang M, Li J, Huang J, Zhou S, Hou X, et al. \u03b2-catenin-controlled tubular cell-derived exosomes play a key role in fibroblast activation via the OPN-CD44 axis. J Extracell Vesicles. 2022;11:e12203. https:\/\/doi.org\/10.1002\/jev2.12203.","journal-title":"J Extracell Vesicles"},{"key":"2739_CR15","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.kint.2019.11.026","volume":"97","author":"X Liu","year":"2020","unstructured":"Liu X, Miao J, Wang C, Zhou S, Chen S, Ren Q, et al. Tubule-derived exosomes play a central role in fibroblast activation and kidney fibrosis. Kidney Int. 2020;97:1181\u201395. https:\/\/doi.org\/10.1016\/j.kint.2019.11.026.","journal-title":"Kidney Int"},{"key":"2739_CR16","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41418-019-0349-y","volume":"27","author":"LL Lv","year":"2020","unstructured":"Lv LL, Feng Y, Wu M, Wang B, Li ZL, Zhong X, et al. Exosomal miRNA-19b-3p of tubular epithelial cells promotes M1 macrophage activation in kidney injury. Cell Death Differ. 2020;27:210\u201326. https:\/\/doi.org\/10.1038\/s41418-019-0349-y.","journal-title":"Cell Death Differ"},{"key":"2739_CR17","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/s41581-022-00608-6","volume":"18","author":"N Mahtal","year":"2022","unstructured":"Mahtal N, Lenoir O, Tinel C, Anglicheau D, Tharaux PL. MicroRNAs in kidney injury and disease. Nat Rev Nephrol. 2022;18:643\u201362. https:\/\/doi.org\/10.1038\/s41581-022-00608-6.","journal-title":"Nat Rev Nephrol"},{"key":"2739_CR18","doi-asserted-by":"publisher","first-page":"8660","DOI":"10.7150\/thno.62820","volume":"11","author":"S Zhao","year":"2021","unstructured":"Zhao S, Li W, Yu W, Rao T, Li H, Ruan Y, et al. Exosomal miR-21 from tubular cells contributes to renal fibrosis by activating fibroblasts via targeting PTEN in obstructed kidneys. Theranostics. 2021;11:8660\u201373. https:\/\/doi.org\/10.7150\/thno.62820.","journal-title":"Theranostics"},{"key":"2739_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2020.112007","volume":"392","author":"H Guan","year":"2020","unstructured":"Guan H, Peng R, Mao L, Fang F, Xu B, Chen M. Injured tubular epithelial cells activate fibroblasts to promote kidney fibrosis through miR-150-containing exosomes. Exp Cell Res. 2020;392:112007. https:\/\/doi.org\/10.1016\/j.yexcr.2020.112007.","journal-title":"Exp Cell Res"},{"key":"2739_CR20","doi-asserted-by":"publisher","first-page":"F664","DOI":"10.1152\/ajprenal.00292.2020","volume":"319","author":"J Wen","year":"2020","unstructured":"Wen J, Ma Z, Livingston MJ, Zhang W, Yuan Y, Guo C, et al. Decreased secretion and profibrotic activity of tubular exosomes in diabetic kidney disease. Am J Physiol Ren Physiol. 2020;319:F664\u201373. https:\/\/doi.org\/10.1152\/ajprenal.00292.2020.","journal-title":"Am J Physiol Ren Physiol"},{"key":"2739_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03460-x","volume":"12","author":"D Liu","year":"2021","unstructured":"Liu D, Liu F, Li Z, Pan S, Xie J, Zhao Z, et al. HNRNPA1-mediated exosomal sorting of miR-483-5p out of renal tubular epithelial cells promotes the progression of diabetic nephropathy-induced renal interstitial fibrosis. Cell Death Dis. 2021;12:255. https:\/\/doi.org\/10.1038\/s41419-021-03460-x.","journal-title":"Cell Death Dis"},{"key":"2739_CR22","doi-asserted-by":"publisher","first-page":"3852","DOI":"10.1016\/j.cell.2021.06.024","volume":"184","author":"MV Plikus","year":"2021","unstructured":"Plikus MV, Wang X, Sinha S, Forte E, Thompson SM, Herzog EL, et al. Fibroblasts: origins, definitions, and functions in health and disease. Cell. 2021;184:3852\u201372. https:\/\/doi.org\/10.1016\/j.cell.2021.06.024.","journal-title":"Cell"},{"key":"2739_CR23","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nrneph.2015.215","volume":"12","author":"D Zhou","year":"2016","unstructured":"Zhou D, Liu Y. Renal fibrosis in 2015: understanding the mechanisms of kidney fibrosis. Nat Rev Nephrol. 2016;12:68\u201370. https:\/\/doi.org\/10.1038\/nrneph.2015.215.","journal-title":"Nat Rev Nephrol"},{"key":"2739_CR24","doi-asserted-by":"publisher","unstructured":"Jeon JS, Kim E, Bae YU, Yang WM, Lee H, Kim H, et al. microRNA in extracellular vesicles released by damaged podocytes promote apoptosis of renal tubular epithelial cells. Cells. 2020;9. https:\/\/doi.org\/10.3390\/cells9061409.","DOI":"10.3390\/cells9061409"},{"key":"2739_CR25","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1111\/1440-1681.13768","volume":"50","author":"L Liu","year":"2023","unstructured":"Liu L, Liu L, Liu R, Liu J, Cheng Q. Exosomal miR-21-5p derived from multiple myeloma cells promote renal epithelial-mesenchymal transition through targeting TGF-\u03b2\/SMAD7 signalling pathway. Clin Exp Pharm Physiol. 2023;50:711\u20138. https:\/\/doi.org\/10.1111\/1440-1681.13768.","journal-title":"Clin Exp Pharm Physiol"},{"key":"2739_CR26","doi-asserted-by":"publisher","unstructured":"Zheng H, Ji J, Zhao T, Wang E, Zhang A. Exosome\u2011encapsulated miR\u201126a attenuates aldosterone\u2011induced tubulointerstitial fibrosis by inhibiting the CTGF\/SMAD3 signaling pathway. Int J Mol Med. 2023;51. https:\/\/doi.org\/10.3892\/ijmm.2022.5214.","DOI":"10.3892\/ijmm.2022.5214"},{"key":"2739_CR27","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.biochi.2018.10.011","volume":"157","author":"J Hu","year":"2019","unstructured":"Hu J, Wu H, Wang D, Yang Z, Dong J. LncRNA ANRIL promotes NLRP3 inflammasome activation in uric acid nephropathy through miR-122-5p\/BRCC3 axis. Biochimie. 2019;157:102\u201310. https:\/\/doi.org\/10.1016\/j.biochi.2018.10.011.","journal-title":"Biochimie"},{"key":"2739_CR28","doi-asserted-by":"publisher","unstructured":"Kaneko S, Yanai K, Ishii H, Aomatsu A, Hirai K, Ookawara S, et al. miR-122-5p regulates renal fibrosis in vivo. Int J Mol Sci. 2022;23. https:\/\/doi.org\/10.3390\/ijms232315423.","DOI":"10.3390\/ijms232315423"},{"key":"2739_CR29","doi-asserted-by":"publisher","first-page":"9701","DOI":"10.2147\/cmar.S225742","volume":"11","author":"S Wang","year":"2019","unstructured":"Wang S, Zheng W, Ji A, Zhang D, Zhou M. Overexpressed miR-122-5p promotes cell viability, proliferation, migration and glycolysis of renal cancer by negatively regulating PKM2. Cancer Manag Res. 2019;11:9701\u201313. https:\/\/doi.org\/10.2147\/cmar.S225742.","journal-title":"Cancer Manag Res"},{"key":"2739_CR30","first-page":"103","volume":"14","author":"X Liu","year":"2022","unstructured":"Liu X, Xu H, Zang Y, Liu W, Sun X. Radix Rehmannia Glutinosa inhibits the development of renal fibrosis by regulating miR-122-5p\/PKM axis. Am J Transl Res. 2022;14:103\u201319.","journal-title":"Am J Transl Res"},{"key":"2739_CR31","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.omtn.2018.04.005","volume":"11","author":"Y Sun","year":"2018","unstructured":"Sun Y, Wang H, Li Y, Liu S, Chen J, Ying H. miR-24 and miR-122 negatively regulate the transforming growth factor-\u03b2\/smad signaling pathway in skeletal muscle fibrosis. Mol Ther Nucleic Acids. 2018;11:528\u201337. https:\/\/doi.org\/10.1016\/j.omtn.2018.04.005.","journal-title":"Mol Ther Nucleic Acids"},{"key":"2739_CR32","doi-asserted-by":"publisher","DOI":"10.34133\/bmr.0013","volume":"28","author":"W Lu","year":"2024","unstructured":"Lu W, Guo Y, Liu H, Zhang T, Zhang M, Li X, et al. The inhibition of fibrosis and inflammation in obstructive kidney injury via the miR-122-5p\/SOX2 axis using USC-Exos. Biomater Res. 2024;28:0013. https:\/\/doi.org\/10.34133\/bmr.0013.","journal-title":"Biomater Res"},{"key":"2739_CR33","doi-asserted-by":"publisher","first-page":"153481","DOI":"10.1016\/j.phymed.2021.153481","volume":"83","author":"W Feng","year":"2021","unstructured":"Feng W, Ying Z, Ke F, Mei-Lin X. Apigenin suppresses TGF-\u03b21-induced cardiac fibroblast differentiation and collagen synthesis through the downregulation of HIF-1\u03b1 expression by miR-122-5p. Phytomedicine. 2021;83:153481. https:\/\/doi.org\/10.1016\/j.phymed.2021.153481.","journal-title":"Phytomedicine"},{"key":"2739_CR34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.bbrc.2022.06.008","volume":"618","author":"D Liu","year":"2022","unstructured":"Liu D, Sun H, Li K, Zhao Z, Liu Z, Zhang G, et al. HIF-1\u03b1 mediates renal fibrosis by regulating metabolic remodeling of renal tubule epithelial cells. Biochem Biophys Res Commun. 2022;618:15\u201323. https:\/\/doi.org\/10.1016\/j.bbrc.2022.06.008.","journal-title":"Biochem Biophys Res Commun"},{"key":"2739_CR35","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/ki.2010.326","volume":"79","author":"Z Wang","year":"2011","unstructured":"Wang Z, Tang L, Zhu Q, Yi F, Zhang F, Li PL, et al. Hypoxia-inducible factor-1\u03b1 contributes to the profibrotic action of angiotensin II in renal medullary interstitial cells. Kidney Int. 2011;79:300\u201310. https:\/\/doi.org\/10.1038\/ki.2010.326.","journal-title":"Kidney Int"},{"key":"2739_CR36","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.kint.2016.05.026","volume":"90","author":"B Baumann","year":"2016","unstructured":"Baumann B, Hayashida T, Liang X, Schnaper HW. Hypoxia-inducible factor-1\u03b1 promotes glomerulosclerosis and regulates COL1A2 expression through interactions with Smad3. Kidney Int. 2016;90:797\u2013808. https:\/\/doi.org\/10.1016\/j.kint.2016.05.026.","journal-title":"Kidney Int"},{"key":"2739_CR37","doi-asserted-by":"publisher","first-page":"3810","DOI":"10.1172\/jci30487","volume":"117","author":"DF Higgins","year":"2007","unstructured":"Higgins DF, Kimura K, Bernhardt WM, Shrimanker N, Akai Y, Hohenstein B, et al. Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J Clin Invest. 2007;117:3810\u201320. https:\/\/doi.org\/10.1172\/jci30487.","journal-title":"J Clin Invest"},{"key":"2739_CR38","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s00109-015-1264-4","volume":"93","author":"J Kalucka","year":"2015","unstructured":"Kalucka J, Schley G, Georgescu A, Klanke B, R\u00f6ssler S, Baumgartl J, et al. Kidney injury is independent of endothelial HIF-1\u03b1. J Mol Med. 2015;93:891\u2013904. https:\/\/doi.org\/10.1007\/s00109-015-1264-4.","journal-title":"J Mol Med"},{"key":"2739_CR39","doi-asserted-by":"publisher","unstructured":"Imamura M, Moon JS, Chung KP, Nakahira K, Muthukumar T, Shingarev R, et al. RIPK3 promotes kidney fibrosis via AKT-dependent ATP citrate lyase. JCI Insight. 2018;3. https:\/\/doi.org\/10.1172\/jci.insight.94979.","DOI":"10.1172\/jci.insight.94979"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02739-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02739-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02739-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T01:02:35Z","timestamp":1761094955000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02739-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2739"],"URL":"https:\/\/doi.org\/10.1038\/s41420-025-02739-8","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"assertion":[{"value":"24 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"474"}}